CTI BIOPHARMA CORP Termination Agreements

5 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No 1. to the Asset Return and Termination Agreement, by and between Baxalta Incorporated and CTI BioPharma Corp., dated as of May 31, 2022
Termination Agreements
CTI BIOPHARMA CORP
Biotechnology
2022
Termination and Transfer Agreement, dated as of February 25, 2019, by and among on the one hand, CTI BioPharma Corp. and CTI Life Sciences Limited, and, on the other hand, Les...
Termination Agreements
CTI BIOPHARMA CORP
Biotechnology
2019
Asset Return and Termination Agreement between Baxalta Incorporated, Baxalta US Inc., Baxalta GmbH, and CTI BioPharma Corp.
Termination Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2016
Termination Agreement between Novartis International Pharmaceutical Ltd. and Cell Therapeutics, Inc. (January 3, 2014)
Termination Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2014
Termination Agreement between Cell Therapeutics, Inc. and Midsummer Investment, Ltd.
Termination Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2009